Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01467115
Title INDUCTION CHEMOTHERAPY FOLLOWED BY CETUXIMAB AND RADIATION THERAPY FOR HEAD AND NECK CANCER
Acronym DREXNECK
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Drexel University
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.